Covered recipient · General Payments record
MARIE LOUISE TCHUEKON SAGAN YEWAH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,952.44
- Reported across 371 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.93 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $156.79 | 3 |
| Novo Nordisk AS | $86.39 | 4 |
| Acerta Pharma LLC | $41.55 | 3 |
| Gilead Sciences, Inc. | $35.95 | 2 |
| GlaxoSmithKline, LLC. | $32.72 | 2 |
| SHIELD THERAPEUTICS INC | $22.79 | 1 |
| ABIOMED | $15.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $15.74 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142269637 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.43 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105491657 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.78 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104779202 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.34 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105352016 | CMS |
| Gilead Sciences, Inc. | $17.84 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133743255 | CMS |
| Gilead Sciences, Inc. | $18.11 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133743257 | CMS |
| GlaxoSmithKline, LLC. | $19.50 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116440921 | CMS |
| GlaxoSmithKline, LLC. | $13.22 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115983791 | CMS |
| Lilly USA, LLC | $15.58 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135160616 | CMS |
| Lilly USA, LLC | $21.51 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166153 | CMS |
| Lilly USA, LLC | $119.70 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148418 | CMS |
| Novo Nordisk Inc | $23.80 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097646366 | CMS |
| Novo Nordisk Inc | $17.42 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097540023 | CMS |
| Novo Nordisk Inc | $22.05 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097285279 | CMS |
| Novo Nordisk Inc | $23.12 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097309512 | CMS |
| SHIELD THERAPEUTICS INC | $22.79 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150117883 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.